- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 17.532 ↓ -0.06%
[as on 6 March, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option and its peers as on 6 March, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| HDFC Pharma and Healthcare Fund - Growth Option | 2.05% | -0.06% | -1.33% | 4.17% | 0.94% | 15.39% | - | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 1.83% | -0.1% | -0.64% | 4.23% | -0.21% | 7.42% | 25.84% | 17.16% | 20.26% | 12.04% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -5.78% | -1.18% | -3.51% | -4.04% | -6.42% | 7.69% | 12.97% | 11.02% | 12.92% | 12.78% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -4.37% | -0.61% | -3.21% | -3.24% | -3.45% | 8.02% | 19.65% | 19.18% | 18.79% | 16.71% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.9% | -0.46% | -2.95% | 1.83% | 8.16% | 28.24% | 32.21% | 26.72% | 20.47% | 16.15% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -7.05% | -0.48% | -2.35% | -3.06% | -7.39% | -0.46% | 11.8% | 14.71% | 13.96% | 14.73% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 50.48% | 0.54% |
Discrete returns (monthly)
| Month | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 |
|---|
| Returns | 0.9% | 3.77% | 5.23% | -1.55% | -1.54% | 2.06% | 1.12% | -1.48% | -4.75% | 6.9% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 6.42% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.31% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.69% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.70% |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.87% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 6.67% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.05% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 5.83% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.49% |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 4.12% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.80% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 3.71% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.63% |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 3.61% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.50% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 2.89% |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 2.88% |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 2.86% |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.46% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.33% |
| Dr. Lal Path Labs Ltd | LALPATHLAB (INE600L01024) | Healthcare Services | 1.88% |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.78% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.72% |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.68% |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.58% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.50% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.29% |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.29% |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 1.27% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.05% |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 1.03% |
| Rubicon Research Limited | RUBICON (INE506V01022) | Healthcare Services | 1.00% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 0.95% |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.89% |
Portfolio data is as on date 31 October, 2025
NAV history
HDFC Pharma and Healthcare Fund - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 6 March, 2026 | 17.532 |
| 5 March, 2026 | 17.543 |
| 4 March, 2026 | 17.323 |
| 2 March, 2026 | 17.625 |
| 27 February, 2026 | 17.769 |
| 26 February, 2026 | 17.911 |
| 25 February, 2026 | 17.721 |
| 24 February, 2026 | 17.523 |
| 23 February, 2026 | 17.519 |
| 20 February, 2026 | 17.348 |
| 19 February, 2026 | 17.367 |
| 18 February, 2026 | 17.465 |
| 17 February, 2026 | 17.412 |
| 16 February, 2026 | 17.311 |
| 13 February, 2026 | 17.181 |
| 12 February, 2026 | 17.454 |
| 11 February, 2026 | 17.431 |
| 10 February, 2026 | 17.205 |
| 9 February, 2026 | 17.128 |
| 6 February, 2026 | 16.83 |
| 5 February, 2026 | 16.864 |
| 4 February, 2026 | 16.755 |
| 3 February, 2026 | 16.781 |
| 2 February, 2026 | 16.364 |
| 30 January, 2026 | 16.488 |
| 29 January, 2026 | 16.367 |
| 28 January, 2026 | 16.475 |
| 27 January, 2026 | 16.44 |
| 23 January, 2026 | 16.404 |
| 22 January, 2026 | 16.613 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option is 17.532 as on 6 March, 2026.
What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option are 2.05% as on 6 March, 2026.
What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option are 15.39% as on 6 March, 2026.